In addition, experiments suggest that miRNAs mediate the carcinogenic effects of progesterone in the breast [26, 27] and it was shown that there are clear differences in miRNA levels in ER+/PR+ breast tumors versus triple negative breast tumors [28, 29]. This evidence concerns the gene ESR1 and breast neoplasm.